Suppr超能文献

Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.

作者信息

Gregoire S L, Grasela T H, Freer J P, Tack K J, Schentag J J

出版信息

Antimicrob Agents Chemother. 1987 Mar;31(3):375-8. doi: 10.1128/AAC.31.3.375.

Abstract

The influence of multiple doses of ofloxacin (ORF 18489) on the disposition of theophylline was studied in 15 male volunteers. Subjects were confined in the Clinical Research Unit for 13 days and given a xanthine-free diet. A single dose (3 mg/kg) of theophylline was given orally, and blood samples were collected at fixed time intervals for 36 h. The concentrations of theophylline were measured with TDX (Abbott Diagnostics, Irving, Tex.), and clearance was calculated. Theophylline clearance was used to individualize subsequent doses to achieve average steady-state theophylline concentrations in plasma of 10 mg/liter. Individualized theophylline doses were administered every 8 h until steady-state conditions were reached. Theophylline clearance was determined again at steady state and on days 7 and 8. On day 8, ofloxacin (400 mg every 12 h) was given concomitantly with theophylline. Theophylline clearance was measured again on day 12, after the last theophylline dose. Administration of ofloxacin for 1 day did not change theophylline clearance, but coadministration for 4 days significantly decreased theophylline clearance by 12.1% (P less than 0.05). The area under the concentration-time curve for theophylline increased 9.9% (P less than 0.05), and average steady-state concentrations in plasma increased 10.3% (P less than 0.05). Despite changes in clearance, adverse effects of theophylline did not increase during coadministration of ofloxacin. Although statistically significant, the interaction between ofloxacin and theophylline is unlikely to be of major clinical importance.

摘要

相似文献

1
Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.
Antimicrob Agents Chemother. 1987 Mar;31(3):375-8. doi: 10.1128/AAC.31.3.375.
2
Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose.
Ther Drug Monit. 1988;10(2):160-3. doi: 10.1097/00007691-198802000-00007.
3
Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration.
Eur J Clin Pharmacol. 1987;32(4):431-2. doi: 10.1007/BF00543982.
5
Lack of effect of ofloxacin on theophylline pharmacokinetics in rats.
Chemotherapy. 1987;33(6):402-11. doi: 10.1159/000238528.
7
Pharmacokinetics of ofloxacin and theophylline alone and in combination.
Infection. 1986;14 Suppl 1:S67-9. doi: 10.1007/BF01645203.
8
The influence of quinolone derivatives on theophylline clearance.
Br J Clin Pharmacol. 1986 Dec;22(6):677-83. doi: 10.1111/j.1365-2125.1986.tb02957.x.
9
Interaction between the fluoroquinolones and the bronchodilator theophylline.
J Antimicrob Chemother. 1988 Sep;22 Suppl C:109-14. doi: 10.1093/jac/22.supplement_c.109.
10
Influence of lomefloxacin on the pharmacokinetics of theophylline.
Antimicrob Agents Chemother. 1990 Jun;34(6):1254-6. doi: 10.1128/AAC.34.6.1254.

引用本文的文献

1
Clinically significant interactions with drugs used in the treatment of tuberculosis.
Drug Saf. 2002;25(2):111-33. doi: 10.2165/00002018-200225020-00005.
2
Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.
Antimicrob Agents Chemother. 1998 Sep;42(9):2359-64. doi: 10.1128/AAC.42.9.2359.
3
Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.
Antimicrob Agents Chemother. 1995 Sep;39(9):2138-40. doi: 10.1128/AAC.39.9.2138.
4
Effect of norfloxacin on theophylline pharmacokinetics at steady state.
Antimicrob Agents Chemother. 1988 Apr;32(4):510-2. doi: 10.1128/AAC.32.4.510.
5
Inhibition of drug metabolism by quinolone antibiotics.
Clin Pharmacokinet. 1988 Sep;15(3):194-204. doi: 10.2165/00003088-198815030-00004.
6
4-quinolones inhibit biotransformation of caffeine.
Eur J Clin Pharmacol. 1988;35(6):651-6. doi: 10.1007/BF00637602.
7
Effect of norfloxacin on theophylline metabolism.
Antimicrob Agents Chemother. 1989 Feb;33(2):212-4. doi: 10.1128/AAC.33.2.212.
8
Fluoroquinolone antimicrobial agents.
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Effect of lomefloxacin on theophylline pharmacokinetics.
Antimicrob Agents Chemother. 1989 Jul;33(7):1006-8. doi: 10.1128/AAC.33.7.1006.
10
Quinolone antimicrobial agents: adverse effects and bacterial resistance.
Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1080-92. doi: 10.1007/BF01975175.

本文引用的文献

1
Alteration of theophylline clearance and half-life by cimetidine in normal volunteers.
Ann Intern Med. 1981 Nov;95(5):582-5. doi: 10.7326/0003-4819-95-5-582.
2
[Neurologic side effects of quinolones].
Therapie. 1982 Jul-Aug;37(4):481-7.
3
In vitro and in vivo activity of DL-8280, a new oxazine derivative.
Antimicrob Agents Chemother. 1982 Oct;22(4):548-53. doi: 10.1128/AAC.22.4.548.
4
The pharmacokinetics and tissue penetration of ofloxacin.
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
5
Theophylline. A "state of the art" review.
Pharmacotherapy. 1983 Jan-Feb;3(1):2-44. doi: 10.1002/j.1875-9114.1983.tb04531.x.
6
Enoxacin raises plasma theophylline concentrations.
Lancet. 1984 Jul 14;2(8394):108-9. doi: 10.1016/s0140-6736(84)90283-6.
7
Effect of rifampicin administration on theophylline pharmacokinetics in humans.
Am Rev Respir Dis. 1985 Jun;131(6):939-40. doi: 10.1164/arrd.1985.131.6.939.
8
In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).
Am Rev Respir Dis. 1985 Mar;131(3):348-51. doi: 10.1164/arrd.1985.131.3.348.
10
Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.
Am Rev Respir Dis. 1985 Mar;131(3):352-6. doi: 10.1164/arrd.1985.131.3.352.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验